- Actigraphy System
- Polysomnography Device (PSG)
- Respiratory Polygraph
- Single-Channel Screening Devices (Pulse Oximeter )
Sleep Apnea Diagnostic Systems Market size was valued at USD 299.4 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 7.1% from 2022 to 2028. Sleep Apnea Diagnostic Systems Market: Sleep apnea is a genuine rest issue that happens when a man's breathing is hindered amid rest. Individuals with untreated rest apnea quit breathing over and over amid their rest, in some cases several times. This implies the mind - and whatever remains of the body - may not get enough oxygen. Increasing number of rehabilitation centres, awareness campaigns to assist patients with neurological disorders which has led to rise in number of patients seeking treatments for neurological disorders. The risk of sleep apnea is greater in age group of 50-60 years. According to UNO estimations in 2012, geriatric population was about 810Mn and it is anticipated to grow over 2000Mn people by 2050 globally. Expanded spotlight on R&D exercises for creating inventive items and key activities, for example, merger and securing and new item dispatch is the significant system embraced by these players to keep up their market position. For example, In May 2017, Philips consented to securing arrangement with Respiratory Technologies, Inc. The obtaining will grow Philips sleep and respiratory care business.
Sleep Apnea Diagnostic Systems Market Summary
Study Period
2023-29
Base Year
2022
CAGR
7.1%
Largest Market
North America
Fastest Growing Market
Asia-Pacific
Growth
Factors such as increase in the prevalence of sleep apnea globally is majorly driving the growth of the market. As per to the National Commission on Sleeping Disorders Research, globally about 38,000 deaths are occurring annually owing to the cardiovascular problems associated with sleepapnea. Furthermore, growing geriatric population, rising lifestyle changes, growing homecare acceptance, growing awareness about health, sleep disorders, improving healthcare infrastructure, introduction of new technologies and innovative products are the few factors which are boosting the growth of the market. However, strict regulatory procedures, side effects associated with the drugs, high competition in the market are the factors which are hampering the sleep apnea diagnostic systems growth.
North-America Got Significant Share
Sleep Apnea Diagnostic Systems Market
Geographically Market is segmented as Latin America, North America, Asia- Pacific, The Middle East & Africa and Europe. North America dominated the market followed by Asia-Pacific and Europe. The factors attributable for North America are having high obesity rates while Europe has large population pool suffering with diabetic retinopathy. Owing to improved infrastructure and awareness among the people especially of emerging markets like China, India and Brazil, there is strong emphasis on the quality of life (QALY) for diabetic patients demanding early detection and treatment of chronic, the market seems to be agile and open.
Latin America
Europe
Asia Pacific
Middle East
North America
Key Features of the Reports
- The report provides granular level information about the market size, regional market share, historic market (2016 to 2021) and forecast (2022 to 2028)
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
- The report tracks recent innovations, key developments and startup’s details that are actively working in the market
- The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
- The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
Sleep Apnea Diagnostic Systems Market Segmentation
Diagnostic Type
End User
- Sleep Laboratories
- Hospitals
- Home Care/Individuals
Geography
North America
- US
- Canada
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
- Japan
- China
- India
- Australia & New Zealand
- ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
- South Korea
- Rest of Asia-Pacific
- Brazil
- Mexico
- Argentina
- Venezuela
- Rest of Latin America
- Gulf Cooperation Council (GCC) Countries
- Israel
- South Africa
- Rest of MEA
Frequently Asked Questions
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.
Market participants
- Koninklijke Philips (Netherlands)
- ResMed (US)
- Fisher & Paykel Healthcare (New Zealand)
- SomnoMed (Australia)
- Löwenstein Medical (Germany)
- Compumedics (Australia)
- Whole You (US)
- Drive DeVilbiss Healthcare (US)
- BMC Medical (China)
- Braebon Medical (Canada)